COMMUNICATING EVIDENCE TO PRESCRIBERS AND PUBLIC ON SAFE USE OF ANTIHISTAMINES AND DECONGESTANTS

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-SAPS-046
• By: NAWAZ, Hafiz Awais (University of Veterinary & Animal Sciences (UVAS), Institute of Pharmaceutical Sciences (IPS), Pakistan)
• Co-author(s): Asma Nadeem: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
  Hafiza Mahnoor Basharat: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
  Alweena Habib: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
  Areeba Ali: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
  Tehreem Akram : Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
  Hafiz Awais Nawaz: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
  Huma Rasheed: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
  
• Abstract:

  Background

  Evidence-based practice (EBP) can contribute to improve health system practices. Lack of communication to the public and prescribers is among the main challenges and leads to irrational therapy. E.g., an excess of cough and cold medications (antihistamines and decongestants) are used in acute respiratory tract infections by prescribers..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login